Popular topics to explore
PharmEasy Parent Narrows Q1 Loss as Revenue Grows 10% YoY
THYROCARE PharmEasy parent API Holdings has reported a significant improvement in its Q1FY27 performance, with its net loss narrowing to ₹29.6 crore from ₹145.4 crore in the same quarter last year. Revenue, meanwhile, increased 10% YoY to…
Stocks With Strong Future Guidance — Worth Tracking
• V-Marc
• RR Kabel
• Finolex
• HFCL HFCL
• E2E Networks
• MTAR Technologies
• Syrma SGS
• Netweb Technologies
• Sterlite Technologies
• Sansera Engineering
• Azad Engineering
• Omnitech Engineering
• Dynamatic Technologies
• Aequs
• Ross…
Technical Analysis Thyrocare Technologies
The stock THYROCARE is showing a strong bullish trend on the weekly chart. The stock has formed a clear higher-high and higher-low structure and has recently broken above its previous ₹520–550 resistance zone with strong momentum. It is c…
Thyrocare Shares Fall 8% After Promoter Sells 10% Stake
THYROCARE shares fell nearly 8% after promoter Docon Technologies sold around 10% of the company's paid-up equity capital, triggering concerns over promoter stake reduction and near-term supply pressure.
Key Details
Shares Sold: 53.33 la…
Thyrocare Technologies Ltd. fell nearly 7% after promoter Docon Technologies Pvt. Ltd. sold there shares
THYROCARE Shares of Thyrocare Technologies Ltd. fell nearly 7% on August 13 after promoter Docon Technologies Pvt. Ltd. sold a 9.9% stake in the diagnostics company through a block deal. According to Bloomberg data, Docon Technologies sold…
🚨 Promoter pledging is something I always check before looking at a stock.
A few mid & smallcap stocks currently have a very high portion of promoter shares pledged. 100% of promoter holding pledged: • Afcons Infra • Bajaj Hindusthan • Indo Borax • Mphasis • Thyrocare Technologies And some others are also above…
Healthcare Stock Review
THYROCARE . is one of India’s leading diagnostic and preventive healthcare service providers, specializing in affordable and reliable pathology tests, including thyroid, diabetes, and wellness profiles, with a nationwide network of diagnos…
THYROCARE sets record date for ₹14 full-year payout.
Thyrocare Technologies Limited declared a final dividend of ₹7 per share for FY26, totaling a payout of ₹14 per share including the interim dividend. The move reflects the company's imp…
Thyrocare Technologies Jumps Over 21% in a Week After Robust Q4 Performance
THYROCARE remained in strong momentum during the week ended 8 May 2026, with the stock rallying over 21.5% on a weekly basis.
The stock extended gains for the fifth consecutive session on Friday, 8 May 2026, rising as much as 11.74% intra…
When Sales Climb but Profits Tell a Different Story - Dr Lal PathLabs Q4 March 2026 Results Learning to compare quarterly results both year on year and quarter on quarter helps investors truly understand a company’s financial health and ma…
Stocks in news today
THYROCARE has made an additional investment of $4,75,000 (equivalent to Rs 4.32 crore) in Thyrocare Laboratories (Tanzania) (Thyrocare Tanzania), subsidiary of the Company by subscribing to Compulsorily Convertible Irredeemable Preference…
Best Pharma & Healthcare Stocks in India! 💊 With strong domestic demand, export growth, and rising healthcare spending, this sector remains structurally strong 📈 🔎 Top Pharma & Healthcare Players: * Dr. Lal PathLabs * Lupin * Kovai Me…
Thyrocare Technologies Q3 FY26 – Healthy Growth with Improving Profitability
Thyrocare delivered a solid performance in the December 2025 quarter, supported by steady growth in diagnostic volumes and improved operating efficiency, leading to strong expansion in earnings. Sales: ↑ 18% YoY to ₹196 crore (vs ₹166 cror…
10,20,30,50 EMA Bullish Crossover!📊 1- CANFINHOME 2- THYROCARE 3- FEDERALBNK 4- POONAWALLA 5- HINDUNILVR 6- JINDALSTEL 7- HCLTECH 8- BEL 9- HYUNDAI 10- MPHASIS 11- DALBHARAT 12- GODREJCP ( Golden Crossover ) 13- MMTC 14- BDL 15- ULTRACEMC…
Thyrocare Technologies Ltd.
THYROCARE is a pan-India diagnostic player with a centralized, low-cost lab model.
It built its franchise around wellness and preventive testing, leveraging B2B partners.
High automation and volume-based pricing drive strong operating…
🔹 Thyrocare Tanks 67% as Stock Turns Ex-Bonus — No Fundamental Risk
Thyrocare shares plunge 67% today due to a 2:1 bonus issue—a technical adjustment, not a business problem. Investors now hold triple the shares, boosting liquidity without impacting fundamentals. #Thyrocare #BonusIssue #StockMarket101 #Mar…
WATCH OUT FOR CORPORATION ACTIONS TODAY
Watch out for the Corporate actions today 28-November-2025 on the below mentioned stocks: - Shares of Aryavan Enterprise, Meera Industries and Nile shall trade ex-dividend today, while shares of Thyrocare Technologies will trade ex-date fo…
Upcoming record date next week: Dividend, bonus issue, stock split & more – HDFCAMC AMC, PFC among 12 companies
Upcoming Dividend, Stock Splits, Bonus Issues: Shares of 12 companies, including HDFC AMC, Power Finance Corporation (PFC), Thyrocare Technologies Limited and Unison Metals Limited, might remain in focus in the upcoming week. These companie…
HDFCAMC and Thyrocare Technologies have set record dates for bonus shares. HDFC AMC's 1:1 bonus issue records date is November 26, while shares will be available for trading on December 3. Thyrocare's 2:1 bonus issue record date is Novembe…
18th Nov · SEBI-Registered Analyst
The Central Pivot by Vineet Saxena (SEBI RA) · 18th Nov
THYROCARE on the move
THYROCARE delivered a strong Q2 FY26: consolidated revenue rose 22% YoY to ₹216.5 cr, and PAT surged 82% to ₹47.9 cr, while normalized EBITDA grew 49% YoY to ₹75.36 cr. They processed a record 53.3 million tests (+21% YoY), showing robust…
